News & Press Releases
Stay up to date about interesting developments, news and press releases from Saillant Therapeutics.
Dutch Saillant Therapeutics to develop generic virus inhibiting therapy based on activation of a cellular master regulator, ending virus replication Nijmegen, The Netherlands, 11 August 2020 -- Saillant Therapeutics, an innovative biotechnology start-up, developing...
Ready to Make a Change?
By our full preclinical package, we will work together with you throughout the process until the commercialization of your drug candidate.